Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tiffani D. Eisenhauer, Mike Matchett, Ralph Heasley, Terri Morton, Krishna Devarakonda, Michael Giuliani, Jim L. Young & Thomas Barrett. (2016) Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets. Drug Development and Industrial Pharmacy 42:1, pages 157-165.
Read now
Read now
Caroline Victorri-Vigneau, Cedric Collin, Catherine Messina-Gourlot, Christel Raffournier, Michel Mallaret, Jérôme Besse, Marie-Anne Courne, Nathalie Richard, Véronique Sébille & Philippe Arnaud. (2014) Designing a tool allowing for a standardized assessment of resistance to drug diversion. Expert Opinion on Drug Delivery 11:7, pages 995-1004.
Read now
Read now
Mellar Davis, Harold W Goforth & Pam Gamier. (2013) Oxycodone combined with opioid receptor antagonists: efficacy and safety. Expert Opinion on Drug Safety 12:3, pages 389-402.
Read now
Read now
Nathaniel Katz, Richard C. Dart, Elise Bailey, Jeremiah Trudeau, Eric Osgood & Florence Paillard. (2011) Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions. The American Journal of Drug and Alcohol Abuse 37:4, pages 205-217.
Read now
Read now
Articles from other publishers (16)
Heather J. Boyce, Vivek S. Dave, Myke Scoggins, Vadim J. Gurvich, Daniel T. Smith, Stephen R. Byrn & Stephen W. Hoag. (2020) Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic
Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo
Tablets. AAPS PharmSciTech 21:3.
Crossref
Crossref
Aaron J. Salwan, Nicholas E. Hagemeier & Sam Harirforoosh. (2018) Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?. Clinical Drug Investigation 38:7, pages 573-577.
Crossref
Crossref
Heather Boyce, Dan Smith, Steve Byrn, Bhawana Saluja, Wen Qu, Vadim J. Gurvich & Stephen W. Hoag. (2018) In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell. AAPS PharmSciTech 19:4, pages 1744-1757.
Crossref
Crossref
A. Edwards, S. Qi, F. Liu, M.B. Brown & W.J. McAuley. (2017) Rationalising polymer selection for supersaturated film forming systems produced by an aerosol spray for the transdermal delivery of methylphenidate. European Journal of Pharmaceutics and Biopharmaceutics 114, pages 164-174.
Crossref
Crossref
Xiaoming Xu, Abhay Gupta, Manar Al-Ghabeish, Silvia N. Calderon & Mansoor A. Khan. (2016) Risk based in vitro performance assessment of extended release abuse deterrent formulations. International Journal of Pharmaceutics 500:1-2, pages 255-267.
Crossref
Crossref
Bing Cai, Håkan Engqvist & Susanne Bredenberg. (2015) Development and evaluation of a tampering resistant transdermal fentanyl patch. International Journal of Pharmaceutics 488:1-2, pages 102-107.
Crossref
Crossref
Robert S. Mansbach & Kerri A. Schoedel. (2015) Incorporation of Abuse Potential Assessment into the Development of New Prescription Drugs. Pharmaceutical Medicine 29:3, pages 141-153.
Crossref
Crossref
Suzanne K. Vosburg, Jermaine D. Jones, Jeanne M. Manubay, Judy B. Ashworth, Douglas Y. Shapiro & Sandra D. Comer. (2013)
A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin
®
(non-TRF) in prescription opioid abusers
. Addiction 108:6, pages 1095-1106.
Crossref
Crossref
Suzanne K. Vosburg, Jermaine D. Jones, Jeanne M. Manubay, Judy B. Ashworth, Irma H. Benedek & Sandra D. Comer. (2012) Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug and Alcohol Dependence 126:1-2, pages 206-215.
Crossref
Crossref
Dennis C. Turk, Alec B. O’Connor, Robert H. Dworkin, Amina Chaudhry, Nathaniel P. Katz, Edgar H. Adams, John S. Brownstein, Sandra D. Comer, Richard Dart, Nabarun Dasgupta, Richard A. Denisco, Michael Klein, Deborah B. Leiderman, Robert Lubran, Bob A. Rappaport, James P. Zacny, Harry Ahdieh, Laurie B. Burke, Penney Cowan, Petra Jacobs, Richard Malamut, John Markman, Edward Michna, Pamela Palmer, Sarah Peirce-Sandner, Jennifer S. Potter, Srinivasa N. Raja, Christine Rauschkolb, Carl L. Roland, Lynn R. Webster, Roger D. Weiss & Kerry Wolf. (2012) Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain 153:10, pages 1997-2008.
Crossref
Crossref
Lynn R. Webster & Perry G. Fine. (2011) Reply. The Journal of Pain 12:6, pages 723-724.
Crossref
Crossref
Robert B. Raffa & Joseph V. PergolizziJrJr. (2010) Opioid Formulations Designed to Resist/Deter Abuse. Drugs 70:13, pages 1657-1675.
Crossref
Crossref
Steven D. Passik. (2009) Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions. Mayo Clinic Proceedings 84:7, pages 593-601.
Crossref
Crossref
Nathaniel Katz, Kathrine Fernandez, Alan Chang, Christine Benoit & Stephen F. Butler. (2008) Internet-based Survey of Nonmedical Prescription Opioid Use in the United States. The Clinical Journal of Pain 24:6, pages 528-535.
Crossref
Crossref
Nathaniel Katz. (2008) Abuse-deterrent opioid formulations: Are they a pipe dream?. Current Rheumatology Reports 10:1, pages 11-18.
Crossref
Crossref
Nathaniel P. Katz, Edgar H. Adams, Howard Chilcoat, Robert D. Colucci, Sandra D. Comer, Philip Goliber, Charles Grudzinskas, Donald Jasinski, Stephen D. Lande, Steven D. Passik, Sidney H. Schnoll, Edward Sellers, Debra Travers & Roger Weiss. (2007) Challenges in the Development of Prescription Opioid Abuse-deterrent Formulations. The Clinical Journal of Pain 23:8, pages 648-660.
Crossref
Crossref